Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
J Clin Psychopharmacol ; 34(2): 205-11, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24525640

RESUMEN

Methadone is a synthetic opioid that binds to the κ-opioid receptor with a low affinity. This study tested the hypotheses that the genetic polymorphisms in the κ-opioid receptor 1 (OPRK1) gene region are associated with methadone treatment responses in a Taiwan methadone maintenance treatment (MMT) cohort. Seventeen single nucleotide polymorphisms (SNPs) in OPRK1 were selected and genotyped on DNA of 366 MMT patients. Six SNPs from rs7843965 to rs1051660 (intron 2 to exon 2) were significantly associated with body weight (P < 0.007). A haplotype of 4 SNPs rs7832417-rs16918853-rs702764-rs7817710 (exon 4 to intron 3) was associated with bone or joint aches (P ≤ 0.004) and with the amount of alcohol use (standard drinks per day; global P < 0.0001). The haplotype rs10958350-rs7016778-rs12675595 was associated with gooseflesh skin (global P < 0.0001), yawning (global P = 0.0001), and restlessness (global P < 0.0001) withdrawal symptoms. The findings suggest that genetic polymorphisms in OPRK1 were associated with the body weight, alcohol use, and opioid withdrawal symptoms in MMT patients.


Asunto(s)
Consumo de Bebidas Alcohólicas/genética , Peso Corporal/genética , Metadona/efectos adversos , Metadona/uso terapéutico , Tratamiento de Sustitución de Opiáceos/efectos adversos , Polimorfismo de Nucleótido Simple/genética , Receptores Opioides kappa/genética , Síndrome de Abstinencia a Sustancias/genética , Adolescente , Adulto , Estudios de Asociación Genética , Haplotipos , Dependencia de Heroína/tratamiento farmacológico , Humanos , Metadona/farmacocinética , Taiwán , Adulto Joven
2.
Pharmacogenomics ; 13(8): 879-88, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22676193

RESUMEN

AIM: To test whether the genetic polymorphisms within the gene encoding the UGT2B7 gene may have an impact on methadone treatment. MATERIALS & METHODS: Twelve SNPs in UGT2B7 were selected. 366 methadone maintenance treatment patients in Taiwan were recruited and genotyped. RESULTS: In a genotype recessive model, rs6600879, rs6600880, rs4554144, rs11940316, rs7438135, rs7662029, rs7668258, rs7439366, rs4292394 and rs6600893 showed significant associations with severity of withdrawal symptoms (permutation p < 0.002), pupil size (permutation p < 0.048) and tremor (permutation p < 0.008). Haplotypes of GATCAGCCGC and CTCTGATTCT were significantly associated with pupil size score and tremor score (p < 0.034). CONCLUSION: These results suggest that SNPs of the UGT2B7 gene may play important roles in opiate withdrawal symptoms.


Asunto(s)
Glucuronosiltransferasa/genética , Metadona , Morfina , Síndrome de Abstinencia a Sustancias/genética , Adulto , Amitriptilina/sangre , Femenino , Estudios de Asociación Genética , Haplotipos , Dependencia de Heroína/tratamiento farmacológico , Dependencia de Heroína/genética , Humanos , Desequilibrio de Ligamiento , Masculino , Metadona/administración & dosificación , Metadona/efectos adversos , Metadona/sangre , Persona de Mediana Edad , Morfina/sangre , Morfina/orina , Polimorfismo de Nucleótido Simple , Pirrolidinas/sangre , Síndrome de Abstinencia a Sustancias/patología , Taiwán
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda